Tudorza Pressair
Tudorza Pressair is an anticholinergic indicated for the long-term, maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). It delivers a dry powder formulation of aclidinium bromide for oral inhalation.
Dosage by Body Weight
The recommended dose is one oral inhalation of 400 mcg twice daily (morning and evening). It is not intended for the relief of acute bronchospasm.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established. COPD is an adult condition.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established. COPD is an adult condition.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established. COPD is an adult condition.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established. COPD is an adult condition.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established. COPD is an adult condition.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients have not been established. COPD is an adult condition. |
| 5-7 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients have not been established. COPD is an adult condition. |
| 8-10 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients have not been established. COPD is an adult condition. |
| 11-15 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients have not been established. COPD is an adult condition. |
| 16-20 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients have not been established. COPD is an adult condition. |
Formulation
Inhalation Powder
Purpose
Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Generic Name
Aclidinium bromideScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.